FNY Investment Advisers’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
CH
PP
RJFSA
RPAM
MCM
FNY Investment Advisers's INMB Position: Q2 2024 in Review
FNY Investment Advisers sold out of INmune Bio (INMB) in Q2 2024, closing a stake of 100 shares — an estimated $1 sold.
FNY Investment Advisers first reported a position in INMB in Q1 2019 and held it in 16 quarters. The position peaked at $75K in Q4 2020. 57 funds tracked by Wall St. Rank hold INMB as of Q2 2024.
- FNY Investment Advisers reported no remaining INmune Bio position as of Q2 2024 after selling out during the quarter.
- FNY Investment Advisers sold 100 INmune Bio shares in Q2 2024, an estimated $1.
- FNY Investment Advisers first reported a position in INmune Bio in Q1 2019 and held it in 16 quarters.
- FNY Investment Advisers's INmune Bio position peaked at $75K in Q4 2020.
- 57 funds tracked by Wall St. Rank held INmune Bio as of Q2 2024.
Based on FNY Investment Advisers's 13F filing for Q2 2024, filed 5 Aug 2024.